LANOXIN
- Product NDC
- 59212-245
- 11-digit product format
- 592120245
- Labeler code
- 59212
- Product ID
- 59212-245_cf61c0cc-0c5d-46b0-ad21-62bda8e75ea7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- digoxin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Concordia Pharmaceuticals Inc.
- Application
- NDA020405
- Marketing category
- NDA
- Marketing start
- 2012-09-30
- Marketing end
- 2019-09-30
- Substance
- DIGOXIN
- Active strength
- 0 mg/1
- Pharmacologic classes
- Cardiac Glycoside [EPC],Cardiac Glycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 59212-245 | D | Discontinued by firm | 2026-08-07 | ||
| excluded package | package | 59212-245 | 59212-245-55 | D | Discontinued by firm | 2026-08-07 | |
| excluded package | package | 59212-245 | 59212-245-75 | D | Discontinued by firm | 2026-08-07 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 59212-245-75 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 59212-245-55 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 59212-245-75 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 59212-245-55 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 59212-245-75 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 59212-245-55 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 59212-245-75 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 59212-245-55 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 59212-245-75 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 59212-245-55 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 59212-245-75 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 59212-245-55 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 59212-245-75 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 59212-245-55 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 59212-245-75 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 59212-245-55 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 59212-245-75 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 59212-245-55 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 59212-245-55 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 59212-245-75 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 59212-245-55 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 59212-245-75 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 59212-245-55 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 59212-245-75 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020405-001 | LANOXIN | DIGOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 |
| N020405-002 | LANOXIN | DIGOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 |
| N020405-003 | LANOXIN | DIGOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | |
| N020405-004 | LANOXIN | DIGOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 |
| N020405-005 | LANOXIN | DIGOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | ||
| N020405-006 | LANOXIN | DIGOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020405-001 | AB |
| N020405-002 | AB |
| N020405-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020405-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020405-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020405-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020405-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020405-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020405-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020405-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020405-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020405-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020405-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020405-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020405-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020405-004 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N020405-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020405-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020405-004 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020405-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020405-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020405-004 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020405-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020405-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020405-004 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020405-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020405-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020405-004 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N020405-001 | AB | 1 | 8072bd15b7f6… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 20d84de3-cb46-44c4-9211-63e833fa2688 | Product name | 2 | 20221214 |
| 4d74103a-bb9b-9034-fbc8-dac635e6e729 | Product name | 3 | 20221117 |
| 5c3aa978-6f46-c7ca-2a83-b57385976bee | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59212-245-55 | LANOXIN | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 59212-245-75 | LANOXIN | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59212-245-55 | EA - Each | 59212-245 | 3b42d3c1-f52d-4641-9629-ce1411eaa870 | 1 | 2016-02-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DIGOXIN | ACTIVE INGREDIENT | 73K4184T59 | LANOXIN (DIGOXIN) TABLET [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| DIGOXIN | ACTIVE MOIETY | 73K4184T59 | LANOXIN (DIGOXIN) TABLET [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| D&C GREEN NO. 5 | INACTIVE INGREDIENT | 8J6RDU8L9X | LANOXIN (DIGOXIN) TABLET [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | LANOXIN (DIGOXIN) TABLET [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | LANOXIN (DIGOXIN) TABLET [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LANOXIN (DIGOXIN) TABLET [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LANOXIN (DIGOXIN) TABLET [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | LANOXIN (DIGOXIN) TABLET [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| STARCH, POTATO | INACTIVE INGREDIENT | 8I089SAH3T | LANOXIN (DIGOXIN) TABLET [CONCORDIA PHARMACEUTICALS INC.] | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LANOXIN | DIGOXIN | Advanz Pharma (US) Corp. | d91e3646-4c63-4512-ab22-db39c085c4dc | 2024-12-05 | Warnings, Adverse reactions | 020405 NDA020405 59212-245 |
| LANOXIN | DIGOXIN | Aphena Pharma Solutions - Tennessee, LLC | f6c7ca21-1c76-4838-8fb9-e1bec6001d8b | 2019-05-08 | Warnings, Adverse reactions | 020405 NDA020405 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 59212-245-55 | 59212024555 | 100 in 1 BOTTLE | Historical |
| 59212-245-75 | 59212024575 | 1000 in 1 BOTTLE | Historical |